UR
EXAS

USCA RIA’s Exact Sciences EXAS Stock Holding History

USCA RIA’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$434K Buy
+3,495
New +$417K 0.03% 423

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

USCA RIA's EXAS Position: Q2 2021 in Review

USCA RIA opened a new position in Exact Sciences (EXAS) in Q2 2021: 3,495 shares worth $434K. The stake represents 0.03% of the portfolio and ranks #423 among its holdings.

622 funds tracked by Wall St. Rank hold EXAS as of Q2 2021.

  • USCA RIA held 3,495 shares of Exact Sciences worth $434K as of Q2 2021.
  • Exact Sciences was a new USCA RIA position in Q2 2021.
  • Exact Sciences made up 0.03% of USCA RIA's portfolio in Q2 2021, its #423 holding.
  • 622 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2021.

Based on USCA RIA's 13F filing for Q2 2021, filed 28 Jul 2021.